Assignee
PRIMUS PHARMACEUTICALS INC
US·11 granted patents·8 pending applications·5 citations·filing 2010–2024
Top patents by PatentIndex Score
19 records- 0189US11918559B2Reduced dose metaxalone formulationsPRIMUS PHARMACEUTICALS INC·Filed 2023·Granted Mar 5, 2024·2 cites·15 claims
- 0286US10456365B2Methods and formulations for supporting and promoting bone healthPRIMUS PHARMACEUTICALS INC·Filed 2017·Granted Oct 29, 2019·2 cites·13 claims
- 0383US11179465B2Topical compositions comprising a corticosteroidPRIMUS PHARMACEUTICALS INC·Filed 2017·Granted Nov 23, 2021·1 cites·15 claims
- 0477US12485111B2Reduced dose metaxalone formulationsPRIMUS PHARMACEUTICALS INC·Filed 2024·Granted Dec 2, 2025·0 cites·10 claims
- 0575US2021386758A1Topical formulations comprising a steroidPRIMUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0672US11844777B2Methods of treating autoimmune microvascular disordersPRIMUS PHARMACEUTICALS INC·Filed 2022·Granted Dec 19, 2023·0 cites·22 claims
- 0767US11278517B2Methods of treating autoimmune microvascular disordersPRIMUS PHARMACEUTICALS INC·Filed 2018·Granted Mar 22, 2022·0 cites·16 claims
- 0867US10300040B2Therapeutic combinations of sesquiterpenes and flavonoidsPRIMUS PHARMACEUTICALS INC·Filed 2018·Granted May 28, 2019·0 cites·15 claims
- 0963US10039740B2Therapeutic combinations of sesquiterpenes and flavonoidsPRIMUS PHARMACEUTICALS INC·Filed 2016·Granted Aug 7, 2018·0 cites·9 claims
- 1059US2024325355A1Reduced dose metaxalone formulationsPRIMUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1157US9066921B2Combination dosage forms and therapies for supporting bone healthPRIMUS PHARMACEUTICALS INC·Filed 2012·Granted Jun 30, 2015·0 cites·4 claims
- 1257US2024382464A1Manufacturing Process for Metaxalone TabletsPRIMUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1354US2024197687A1Methods of treating neuroinflammation and inhibiting monoamine oxidase-a and restoring/upregulating/increasing il-13 and and pgc-1 by administering oral dosage form containing micronized and nonmicronized particulate metaxalone, alginic acid and propylene glycol alginatePRIMUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1453US2019380999A1Combinations of genistein and bisphosphonatesPRIMUS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1552US9486438B2Combination dosage forms and therapies for supporting bone healthPRIMUS PHARMACEUTICALS INC·Filed 2015·Granted Nov 8, 2016·0 cites·9 claims
- 1648US2020405693A1Reduced dose metaxalone formulationsPRIMUS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1747US10391114B2Therapeutic combinations of curcuminoids and flavonoidsPRIMUS PHARMACEUTICALS INC·Filed 2016·Granted Aug 27, 2019·0 cites·8 claims
- 1836US2018064681A1Therapeutic combinations of curcuminoids and flavonoidsPRIMUS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1935US2010190733A1Methods of Treating Muscular DystrophiesPRIMUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PRIMUS PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →